Rapid Clinical Remission With Upadacitinib in a Pediatric Patient With Refractory Crohn's Disease

被引：7

作者：

Collen, Lauren, V ^{[1
,2
,3
]}

机构：

[1] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA

[2] Harvard Med Sch, Boston, MA USA

[3] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, 300 Longwood Ave,Enders 670, Boston, MA 02115 USA

来源：

INFLAMMATORY BOWEL DISEASES | 2023年 / 29卷 / 07期

关键词：

upadacitinib; pediatric; Crohn's disease; inflammatory bowel disease; JAK inhibitor;

D O I：

10.1093/ibd/izad048

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Lay Summary A pediatric patient with Crohn's disease refractory to anti-tumor necrosis factor therapy, vedolizumab, ustekinumab, and 6-mercaptopurine achieved rapid clinical remission with upadacitinib. This is the first report of successful use of upadacitinib in pediatric inflammatory bowel disease.

引用

页码：1175 / 1176

页数：2

共 6 条

[1] Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease [J].

Chugh, Rishika ;

Braga-Neto, Manuel B. ;

Fredrick, Thomas W. ;

Ramos, Guilherme P. ;

Terdiman, Jonathan ;

El-Nachef, Najwa ;

Loftus, Edward, V ;

Mahadevan, Uma ;

Kane, Sunanda, V .

JOURNAL OF CROHNS & COLITIS, 2022, :504-512

[2] Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn?s Disease in the CELEST Extension Study [J].

D'Haens, Geert ;

Panes, Julian ;

Louis, Edouard ;

Lacerda, Ana ;

Zhou, Qian ;

Liu, John ;

Loftus, Edward V., Jr. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) :2337-+

[3]

Danese S, 2022, LANCET, V399, P2113, DOI [10.1016/s0140-6736(22)00581-5, 10.1016/S0140-6736(22)00581-5]

[4]

Friedman M, 2017, J CROHNS COLITIS, V11, pS432

[5] Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort [J].

Kurowski, Jacob A. ;

Milinovich, Alex ;

Ji, Xinge ;

Bauman, Janine ;

Sugano, David ;

Kattan, Michael W. ;

Achkar, Jean-Paul .

INFLAMMATORY BOWEL DISEASES, 2021, 27 (07) :1035-1044

[6] Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis [J].

Sandborn, William J. ;

Ghosh, Subrata ;

Panes, Julian ;

Schreiber, Stefan ;

D'Haens, Geert ;

Tanida, Satoshi ;

Siffledeen, Jesse ;

Enejosa, Jefferey ;

Zhou, Wen ;

Othman, Ahmed A. ;

Huang, Bidan ;

Higgins, Peter D. R. .

GASTROENTEROLOGY, 2020, 158 (08) :2139-+

← 1 →